Last updated: June 27, 2023
Sponsor: All India Institute of Medical Sciences, New Delhi
Overall Status: Active - Recruiting
Phase
N/A
Condition
Williams Syndrome
Dyslexia
Treatment
Transcranial magnetic stimulation (Hf rTMS)
Clinical Study ID
NCT05923645
IECPG-758/30.11.2022
Ages 6-18 All Genders
Study Summary
Eligibility Criteria
Inclusion
Inclusion Criteria:
- Indian school going children aged 6-18 years having specific learning disorder (SLD)with dyslexia diagnosed by DSM-5 criteria
- English as one of the languages in school
- Parents willing for the study
Exclusion
Exclusion Criteria:
- Parents not willing to participate or follow up at desired frequency of study
- Child who has already received or is on remedial intervention within last 12 weeksprovided by Child Psychologist/ Clinician/Psychiatrist
- Children who participated in a completed DM dissertation on remedial program in SLD
- Child already on any psychotropic medications
- Neurological or psychiatric disorder other than comorbid disorders of SLD
- Uncontrolled epilepsy as defined by seizure frequency >1/month for preceding 3 months
- Severe concurrent illness or disease or unstable medical conditions
- Any contraindications for MRI like presence of pacemaker, metallic implant
- Any contraindications for TMS like Implanted electronic device and non-removablemetallic objects near coil e.g. pacemaker, cochlear implant; presence of ferromagneticmetal in the head outside the mouth; on medication lowering seizure threshold.
Study Design
Total Participants: 60
Treatment Group(s): 1
Primary Treatment: Transcranial magnetic stimulation (Hf rTMS)
Phase:
Study Start date:
January 01, 2023
Estimated Completion Date:
December 31, 2025
Study Description
Connect with a study center
All India Institute of Medical Sciences
Delhi, 110029
IndiaActive - Recruiting


Not the study for you?
Let us help you find the best match. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.